Kerdica 20

Kerdica 20

manidipine

Manufacturer:

MacroPhar

Distributor:

MacroPhar Lab
Concise Prescribing Info
Contents
Manidipine HCl
Indications/Uses
Mild to moderate essential HTN, HTN w/ renal impairment, & severe HTN.
Dosage/Direction for Use
Initially: 10 mg once daily. May be increased to 20 mg once daily after 1-2 wk.
Administration
Should be taken with food: Take after breakfast.
Contraindications
Hypersensitivity. Pregnancy & lactation.
Special Precautions
Severe hepatic impairment. W/draw gradually, if necessary. May impair ability to drive or operate machinery. Childn. Elderly.
Adverse Reactions
Hypersensitivity. Elevation of liver enzymes, BUN, serum creatinine, total cholesterol, uric acid or triglycerides. Leucopenia, GI disturbances, dizziness, headache, facial hot flushes, feeling of warmth, conjunctival congestion, palpitation or tachycardia. Weakness, edema, pollakiuria.
Drug Interactions
Increased blood digoxin conc w/ nifedipine. Intensified action w/ other antihypertensive drugs. Concomitant use w/ cimetidine may intensify other Ca antagonists action.
MIMS Class
ATC Classification
C08CA11 - manidipine ; Belongs to the class of dihydropyridine derivative selective calcium-channel blockers with mainly vascular effects. Used in the treatment of cardiovascular diseases.
Presentation/Packing
Form
Kerdica 20 tab 20 mg
Packing/Price
10 × 10's
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Sign up for free
Already a member? Sign in